Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

This study has been completed.
Hoffmann-La Roche
Information provided by:
St. Louis University Identifier:
First received: September 8, 2005
Last updated: November 19, 2007
Last verified: November 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):